Skip to Main Content

Paper Details

Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss.
Oncogene
3
2021
Author NameAffiliation
Alex LookDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2